Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nivolumab, Pembrolizumab
DRUG
2 trials
Sponsors
National University Hospital, Singapore
, St. Petersburg State Pavlov Medical University
Conditions
Hodgkin Lymphoma
Solid Tumor
Phase 1
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
NCT05175235
National University Hospital, Singapore
Solid Tumor
Start: 2021-08-19
End: 2023-08-01
Target: 10
Updated: 2023-03-03
Phase 2
PD-1 Inhibitors Maintenance for cHL Post-autoHCT
Recruiting
NCT06812858
St. Petersburg State Pavlov Medical University
Hodgkin Lymphoma
Start: 2024-09-02
End: 2030-09-30
Target: 83
Updated: 2025-08-19